IMAX (NYSE:IMAX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Benchmark in a research note issued to investors on Friday, Benzinga reports. They presently have a $22.00 price objective on the stock. Benchmark’s target price would indicate a potential upside of 28.81% from the company’s previous close. Several other equities […]